1. Reszke R, Pełka D, Walasek A, Machaj Z, Reich A. Skin disorders in elderly subjects. Int J Dermatol. 2015; 54:e332–e338.
Article
2. Kaya G, Saurat JH. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology. 2007; 215:284–294.
Article
3. McKnight B, Seidel R, Moy R. Topical human epidermal growth factor in the treatment of senile purpura and the prevention of dermatoporosis. J Drugs Dermatol. 2015; 14:1147–1150.
4. Zhu GA, Raber I, Sakshuwong S, Li S, Li AS, Tan C, et al. Estimation of individual cumulative ultraviolet exposure using a geographically-adjusted, openly-accessible tool. BMC Dermatol. 2016; 16:1.
Article
5. Vandervord JG, Tolerton SK, Campbell PA, Darke JM, Loch-Wilkinson AM. Acute management of skin tears: a change in practice pilot study. Int Wound J. 2016; 13:59–64.
Article
6. Rallis TM, Bakhtian S, Pershing LK, Krueger GG. Effects of 0.1% retinoic acid on Bateman's actinic purpura. Arch Dermatol. 1995; 131:493–495.
Article
7. Saurat JH, Mengeaud V, Georgescu V, Coutanceau C, Ezzedine K, Taïeb C. A simple self-diagnosis tool to assess the prevalence of dermatoporosis in France. J Eur Acad Dermatol Venereol. 2017; 31:1380–1386.
Article
8. Chen W, Jump DB, Grant MB, Esselman WJ, Busik JV. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci. 2003; 44:5016–5022.
Article
9. Keulen ET, Schaper NC, Houben AJ, van Lin JM, Lutgens I, Rijkers K, et al. Reduced structural and functional skin capillaries in familial combined hyperlipidemia affected men, associated with increased remnant-like lipoprotein cholesterol levels. Atherosclerosis. 2002; 163:355–362.
Article
10. Whitmore SE, Levine MA. Risk factors for reduced skin thickness and bone density: possible clues regarding pathophysiology, prevention, and treatment. J Am Acad Dermatol. 1998; 38:248–255.
Article